HEALTH FOCUS: NIH targets rare conditions: ‘Drug-development pipeline’ announced
The National Institutes of Health is launching the first integrated drug-development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases Program, or TRND.